М.V. Vlasenkо

2.1k total citations
15 papers, 24 citations indexed

About

М.V. Vlasenkо is a scholar working on Epidemiology, Neurology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, М.V. Vlasenkо has authored 15 papers receiving a total of 24 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Epidemiology, 3 papers in Neurology and 3 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in М.V. Vlasenkо's work include Neurological Disorders and Treatments (3 papers), Chronic Disease Management Strategies (2 papers) and Vitamin D Research Studies (2 papers). М.V. Vlasenkо is often cited by papers focused on Neurological Disorders and Treatments (3 papers), Chronic Disease Management Strategies (2 papers) and Vitamin D Research Studies (2 papers). М.V. Vlasenkо collaborates with scholars based in Ukraine, Netherlands and Kazakhstan. М.V. Vlasenkо's co-authors include Н. О. Перцева, Iuliia Komisarenko, Vera Popović, Л.К. Соколова, Douglas W. Axelrod, С. В. Павлов, Mónica Popa, Olena Mandrik, Boris Mankovsky and Н. А. Кравчун and has published in prestigious journals such as SHILAP Revista de lepidopterología, Growth Hormone & IGF Research and Journal of Multidisciplinary Healthcare.

In The Last Decade

М.V. Vlasenkо

10 papers receiving 21 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
М.V. Vlasenkо Ukraine 4 15 5 4 4 4 15 24
Н. А. Кравчун Ukraine 4 15 1.0× 3 0.6× 3 0.8× 4 1.0× 1 0.3× 29 33
Balaji Rajagopalan India 4 18 1.2× 2 0.4× 4 1.0× 6 1.5× 1 0.3× 10 32
Su Ann Tee United Kingdom 5 27 1.8× 9 1.8× 4 1.0× 6 1.5× 5 1.3× 6 49
Hajira Masood India 3 5 0.3× 10 2.0× 2 0.5× 3 0.8× 6 1.5× 5 22
Anushree Tiku Australia 2 6 0.4× 4 0.8× 4 1.0× 2 0.5× 2 24
José María Pascual Izuel Spain 4 7 0.5× 4 0.8× 4 1.0× 2 0.5× 8 30
Pedro J. Quiroga-Padilla Colombia 4 7 0.5× 2 0.5× 2 0.5× 3 0.8× 7 17
Н. О. Перцева Ukraine 3 10 0.7× 2 0.4× 1 0.3× 3 0.8× 20 21
Elizabeth M. Bright Nigeria 2 7 0.5× 2 0.4× 3 0.8× 6 1.5× 4 1.0× 2 15
Dayong Gao China 4 15 1.0× 2 0.4× 7 1.8× 8 36

Countries citing papers authored by М.V. Vlasenkо

Since Specialization
Citations

This map shows the geographic impact of М.V. Vlasenkо's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by М.V. Vlasenkо with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites М.V. Vlasenkо more than expected).

Fields of papers citing papers by М.V. Vlasenkо

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by М.V. Vlasenkо. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by М.V. Vlasenkо. The network helps show where М.V. Vlasenkо may publish in the future.

Co-authorship network of co-authors of М.V. Vlasenkо

This figure shows the co-authorship network connecting the top 25 collaborators of М.V. Vlasenkо. A scholar is included among the top collaborators of М.V. Vlasenkо based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with М.V. Vlasenkо. М.V. Vlasenkо is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Vlasenkо, М.V., et al.. (2024). Endothelial dysfunction in patients with different obesity phenotypes. SHILAP Revista de lepidopterología. 20(5). 383–388.
3.
Vlasenkо, М.V., et al.. (2022). DIABETES MELLITUS TYPE 1 IN ADOLESCENTS: IMPACT OF VITAMIN D STATUS. Wiadomości Lekarskie. 75(2). 387–392. 2 indexed citations
6.
Vlasenkо, М.V., et al.. (2019). Застосування Нуклео Ц.М.Ф. форте в комплексному лікуванні діабетичної полінейропатії. SHILAP Revista de lepidopterología. 15(5). 386–390. 1 indexed citations
7.
Vlasenkо, М.V., et al.. (2018). Терапевтичні маски гіпотиреозу. SHILAP Revista de lepidopterología. 14(5). 503–507. 5 indexed citations
9.
Vlasenkо, М.V., et al.. (2016). Вітамін D і цукровий діабет 1-го типу. SHILAP Revista de lepidopterología. 95–98. 1 indexed citations
10.
Popa, Mónica, Vera Popović, М.V. Vlasenkо, et al.. (2014). OR7-6: Safety and efficacy of ARX201: six month dose-ranging study of a novel long-acting pegylated growth hormone in young adults with growth hormone deficiency. Growth Hormone & IGF Research. 24. S20–S20. 3 indexed citations
11.
Mandrik, Olena, Boris Mankovsky, Н. А. Кравчун, et al.. (2013). Impact of hypoglycemia on daily life of type 2 diabetes patients in Ukraine. Journal of Multidisciplinary Healthcare. 6. 249–249. 3 indexed citations
13.
Vlasenkо, М.V.. (2012). Гипоталамический синдром. SHILAP Revista de lepidopterología. 70–76.
14.
15.
Vlasenkо, М.V., et al.. (1990). [Lipid peroxidation in patients with chronic adrenal cortex failure].. PubMed. 36(1). 37–40. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026